Antibacterial Activities of Various Antibiotics Against Clinical Isolates of Escherichia coli

Antibiotics Against Gram Negative Bacteria

Authors

  • Ansar Abbas Virtual University, Lahore, Pakistan

DOI:

https://doi.org/10.54393/pbmj.v5i10.841

Keywords:

Antibiotics, Gram Negative Bacteria, Diseases, Patients

Abstract

Antibiotics are a vital tool in the treatment of a wide range of bacterial diseases, but their overuse and abuse are leading to bacterial resistance. Objectives: To check the antibacterial activities of various antibiotics against E. coli. Methods: Collection of samples was done from patients at the Fatima Memorial Hospital's pathology department in Lahore, Pakistan, for this investigation. Total of 170 clinical isolates of E. coli were isolated from all samples collected. Conventional culture and biochemical tests were used for the identification of bacteria. Antibacterial activity were assessed by comparing antibiotic susceptibility patterns of all clinical isolates to commercial antibiotic discs (cefazolin, cefepime, cefixime, cefotaxime, cefoxitin, ceftriaxone, ceftazidime, cefuroxime, cephalothin, amikacin, amoxycillin, ampicillin, Augmentin, ciprofloxacin, clindamycin, gentamycin, imipenem, levofloxacin, linezolid, meropenem, nalidixic acid, nitrofurantoin, norfloxacin, ofloxacin, rifampicin, and vancomycin) by using Kirby-Bauer disc diffusion method. Results: Antibiotics which showed high sensitivity against Escherichia coli were imipenem (100%), nitrofurantoin (100%), gentamycin (99%) and amikacin (92%). Escherichia coli were showing high resistance to meropenem (100%), ceftazidime (98%), cefepime (78%), ofloxacin (78%), cefuroxime (78%), cefazolin (74%) and ciprofloxacin (65%). Conclusions: We concluded that meropenem, ampicillin, cefuroxime and cefepime showed widespread resistance against all E. coli clinical isolates. There is need to improve the technical facilities to minimize the antibiotic resistance by selecting appropriate antibiotics and proper hand washing recommended.

References

Acar J, Davies J, Buckley M, Antibiotic resistance: an ecological perspective on an old problem. American Society of Microbiology. 2009.

Hasan B, Perveen K, Olsen B, Zahra R. Emergence of carbapenem-resistant Acinetobacter baumannii in hospitals in Pakistan. Journal of medical microbiology. 2014 Jan; 63(1): 50-5.doi: 10.1099/jmm.0.063925-0

Gould IM and Bal AM. New antibiotic agents in the pipeline and how they can help overcome microbial resistance. Virulence. 2013 Feb; 4(2): 185-91. doi: 10.4161/viru.22507

Iredell J, Brown J, Tagg K. Antibiotic resistance in Enterobacteriaceae: mechanisms and clinical implications. Bmj. 2016 Feb; 352. doi: 10.1136/bmj.h6420

Haq FU, Imran M, Saleem S, Aftab U, Ghazal A. Investigation of Morchella esculenta and Morchella conica for their antibacterial potential against methicillin-susceptible Staphylococcus aureus, methicillin-resistant Staphylococcus aureus and Streptococcus pyogenes. Archives of Microbiology. 2022 July; 204(7): 1-13. doi: 10.1007/s00203-022-03003-8

Arnott A, Wang Q, Bachmann N, Sadsad R, Biswas C, Sotomayor C, et al. Multidrug-Resistant Salmonella enterica 4,[5], 12: i: -Sequence Type 34, New South Wales, Australia, 2016-2017. Emerging Infectious Diseases. 2018 Apr; 24(4): 751-53. doi: 10.3201/eid2404.171619

Kaleem F, Usman J, Hassan A, Omair M, Khalid A, Uddin R. Sensitivity pattern of methicillin resistant Staphylococcus aureus isolatedfrom patients admitted in a tertiary care hospital of Pakistan. Iranian journal of microbiology. 2010; 2(3): 141-3.

Walsh TR. Emerging carbapenemases: a global perspective. International journal of antimicrobial agents. 2010 Nov; 36: S8-14. doi: 10.1016/S0924-8579(10)70004-2

Klemm EJ, Shakoor S, Page AJ, Qamar FN, Judge K, Saeed DK, et al. Emergence of an extensively drug-resistant Salmonella enterica serovar Typhi clone harboring a promiscuous plasmid encoding resistance to fluoroquinolones and third-generation cephalosporins. MBio. 2018 Mar; 9(1): e00105-18. doi: 10.1128/mBio.00105-18

Rasheed F, Saeed M, Alikhan NF, Baker D, Khurshid M, Ainsworth EV, et al. Emergence of resistance to fluoroquinolones and third-generation cephalosporins in Salmonella Typhi in Lahore, Pakistan. Microorganisms. 2020 Sep; 8(9). doi: 10.3390/microorganisms8091336

Kilonzo-Nthenge A, Rotich E, Godwin S, Nahashon S, Chen F. Prevalence and antimicrobial resistance of Cronobacter sakazakii isolated from domestic kitchens in middle Tennessee, United States. Journal of food protection. 2012 Aug; 75(8): 1512-7. doi: 10.4315/0362-028X.JFP-11-442

Guo Y, Zhou H, Qin L, Pang Z, Qin T, Ren H, et al. Frequency, antimicrobial resistance and genetic diversity of Klebsiella pneumoniae in food samples. PLoS One. 2016 Apr; 11(4). doi: 10.1371/journal.pone.0153561

Poorabbas B, Mardaneh J, Rezaei Z, Kalani M, Pouladfar G, Alami MH, et al. Nosocomial Infections: Multicenter surveillance of antimicrobial resistance profile of Staphylococcus aureus and Gram negative rods isolated from blood and other sterile body fluids in Iran. Iranian journal of microbiology. 2015 Jun; 7(3): 127-35

Exner M, Bhattacharya S, Christiansen B, Gebel J, Goroncy-Bermes P, Hartemann P, et al. Antibiotic resistance: What is so special about multidrug-resistant Gram-negative bacteria?. GMS hygiene and infection control. 2017; 12: 1-24.

Haq FU, Imran M, Saleem S, Waheed Y. Antibacterial Activity of Different Extracts of Ascomata of Morchella conica and M. esculenta (Ascomycota) against Salmonella Species. International Journal of Medicinal Mushrooms. 2022; 24(9): 85-95. doi: 10.1615/IntJMedMushrooms.2022044572

Javeed I, Hafeez R, Anwar MS. Antibiotic susceptibility pattern of bacterial isolates from patients admitted to a tertiary care hospital in Lahore. Biomedica. 2011 Jan; 27(2): 19-23.

Fluit A, Verhoef J, Schmitz F, Sentry Participants TE. Frequency of isolation and antimicrobial resistance of gram-negative and gram-positive bacteria from patients in intensive care units of 25 European university hospitals participating in the European arm of the SENTRY Antimicrobial Surveillance Program 1997-1998. European journal of clinical microbiology and infectious diseases. 2001 Sep; 20: 617-25. doi: 10.1007/s100960100564

Barakoti A, Guragain A, Adhikari RP, Amatya R. Profile and antimicrobial susceptibility pattern of aerobic bacterial isolates from pus/wound swab samples in a tertiary care hospital, Kathmandu. Nepal Medical College Journal. 2017 Jan; 19(4): 179-83.

Babypadmini S and Appalaraju B. Extended spectrum β-lactamases in urinary isolates of Escherichia coli and Klebsiella pneumoniae-prevalence and susceptibility pattern in a tertiary care hospital. Indian Journal of medical microbiology. 2004 Jul; 22(3): 172-4.

Baldwin CM, Lyseng-Williamson KA, Keam SJ. Meropenem: a review of its use in the treatment of serious bacterial infections. Drugs. 2008 Apr; 68: 803-38. doi: 10.2165/00003495-200868060-00006

Downloads

Published

2022-10-31
CITATION
DOI: 10.54393/pbmj.v5i10.841
Published: 2022-10-31

How to Cite

Abbas, A. . (2022). Antibacterial Activities of Various Antibiotics Against Clinical Isolates of Escherichia coli : Antibiotics Against Gram Negative Bacteria. Pakistan BioMedical Journal, 5(10), 40–43. https://doi.org/10.54393/pbmj.v5i10.841

Issue

Section

Original Article

Plaudit

Similar Articles

You may also start an advanced similarity search for this article.